Fatigue | Mind-Body | Precision Medicine Trials, 12/18/2023

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Cancer Fatigue   Fatigue is a common side effect of cancer and cancer treatment. This updated page explains the causes of cancer fatigue and what you can do to manage it. Read More Virtual Mind–Body Fitness Classes Show Benefit in People with Cancer   In a clinical trial, people being treated for cancer who took part in mind–body fitness classes live over Zoom were less likely to be admitted to the hospital and had shorter stays when they were in the hospital than people who did not take the classes. Read More What Comes after NCI-MATCH? NCI's New Precision Medicine Cancer Trials   NCI's James H. Doroshow, M.D., reflects on NCI-MATCH, a first-of-its-kind precision medicine cancer trial. He also gives an overview of the three new trials to come out of NCI-MATCH: ComboMATCH, MyeloMATCH, and iMATCH. Read More Antibody Drug Ejects Problematic Proteins from Cancer Cells Antibodies used in many cancer treatments have only been able to reach proteins outside of cancer cells. In a new study in mice, scientists found a way to target cancer-fueling KRAS and IDH1 proteins buried inside cancer cells. Read More New Treatment Option for Nasopharyngeal Cancer The Food and Drug Administration has approved toripalimab-tpzi (Loqtorzi) to be used alone or with other drugs to treat nasopharyngeal cancer. It is used in certain adults whose cancer has spread, come back, and cannot be removed with surgery. Read More   Contact Us   Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892